Nebulizer Market Expected to Reach $2.3 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Nebulizer Market," The nebulizer market size was valued at $1.1 billion in 2022, and is estimated to reach $2.3 billion by 2032, growing at a CAGR of 7.8% from 2023 to 2032.

Nebulizers are used by patients with respiratory disorders to provide medicine directly into their lungs. These devices usually include a motor, a mouthpiece that has been cut, and tubing, split up liquid drugs into aerosols by utilizing compressed air, oxygen, or ultrasonic energy. Doctors prescribe this nebulizer to people who have trouble taking deep breaths. The nebulizer treatment facilitates easier airflow into and out of the lungs by relaxing the breathing muscles. It also aids in clearing pulmonary mucus. These two advantages of nebulizer therapy aid in reducing and avoiding wheezing, dyspnea, coughing, and chest tightness. It also helps treat chronic obstructive pulmonary disease (COPD), asthma, and other long-term respiratory conditions.

The nebulizer market size is driven by increase in population suffering from respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other. For instance, according to the Journal The BMJ, published in 2022, Globally, COPD accounted for 212.3 million prevalent cases, 3.3 million deaths. Thus, rise in prevalence of chronic obstructive pulmonary disease is anticipated to boost the demand for nebulizer and is anticipated to boost the growth of the market.

Moreover, rise in geriatric populations is anticipated to drive the growth of the market. For instance, in 2022, according to united nations office for the coordination of humanitarian affairs (OCHA), it was reported that, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. In addition, according to National Library of Medicine, it was reported that aging is the highest demographic risk factor for idiopathic pulmonary fibrosis (IPF). Similarly, chronic obstructive pulmonary disease (COPD) is a common disease in elderly patients. It is characterized by high symptom burden, healthcare utilization, mortality. Thus, rise in geriatric populations is anticipated to increase in population suffering from respiratory diseases. Thus, this factor is anticipated to fuel the demand for nebulizer and boost the growth of the market.

However, nebulizers face competition from other inhalation devices such as metered-dose inhalers (MDIs) and dry powder inhalers (DPIs), which can be more cost-effective and convenient for certain patients. Some patients may prefer these alternatives; thus, this factor is expected to hinder the growth of the nebulizer market.

In addition, rise in awareness among the people regarding nebulizer and increase in use of nebulizer in homecare setting provide lucrative opportunities for the growth of the market.

By type, the nebulizer market share is classified into jet nebulizer, ultrasonic nebulizer, and mesh nebulizer. The jet nebulizer segment is expected to be the fastest growing segment during the forecast period as aerosolized drug delivery by nebulization has historically been accomplished through jet-based systems. Higher use of jet devices has been facilitated by their clinically demonstrated technical benefits and relatively reduced prices. However, the mesh nebulizer segment is anticipated to grow during the forecast period owing to technological advancement in the healthcare sector and rise in adoption of technologically advanced devices by population.

By product, the nebulizer market share is segmented into equipment and accessories. The accessories segment is expected to be the fastest growing segment during the forecast period owing to, rise in use of nebulization for respiratory disease and increase in awareness among people regarding appropriate use of nebulizer. However, equipment segment is expected to grow during the forecast period owing to technological advancement in the different types of nebulizer devices.

By application the nebulizer market trends is segmented into COPD, asthma, and others. The COPD segment is expected to be the fastest growing segment during the forecast period owing to increase in use of nebulization procedure in the treatment of COPD and effectiveness of nebulization in the treatment. However, asthma segment if expected to drive the nebulizer market growth in the forecast period owing to, rise in prevalence of asthma and increase in use of nebulizers in homecare setting for treatment of asthma.

By portability, the market is categorized into tabletop and portable. The tabletop segment is projected to be the fastest growing segment during the forecast period owing to increase in usage of tabletop nebulizers by hospitals and clinics and availability of high number of devices. However, portable segment is anticipated to dominate the nebulizer market forecast owing to adoption of portable nebulizers for homecare setting by population.

By end user, the nebulizer market analysis is segmented into hospitals, clinics, and homecare setting. The hospitals segment is projected to be the fastest growing segment during the forecast period owing to increase in prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other long-term respiratory conditions which got treated in hospital. However, the clinics segment is anticipated to grow during the forecast period for nebulizer market opportunity owing to rise in number of clinical visits by geriatric population and increase in number of clinic consultations.

Region-wise, North America held the highest market share in 2022 and is expected to maintain its lead during the forecast period owing to presence of large market players and highly developed healthcare infrastructure. However, Asia-Pacific is expected to exhibit fastest growth during the forecast period owing to rise in populations suffering from respiratory diseases and increase in awareness among the population regarding use of nebulizer in homecare setting.

Key Findings of The Study

• By type, the jet nebulizer segment dominated the market in 2022.
• By product, the accessories segment dominated the nebulizer industry in 2022.
• By application, the COPD segment dominated the nebulizer industry in 2022.
• By portability, the tabletop segment dominated the market in 2022.
• By end user, hospital segment dominated the market in 2022.
• By region, North America dominated the market in 2022 and is expected to grow during the forecast period.